The receptor tyrosine kinase FLT3 belongs to the type III receptor tyrosine kinase family and is preferentially expressed in acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) cells in addition to hematopoietic stem cells, brain, placenta and liver [1, 2]. The gene discussed is NTRK1; the disease is acute myeloid leukemia.